| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 25,000 | 26 Jun 2025 | Direct | ||
| Senti Biosciences, Inc. | Director | Stock Option (Right to Buy) | 21,950 | 25 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 17:00 |
| SNTI | Senti Biosciences, Inc. | 25 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 19:53 |
| SNTI | Senti Biosciences, Inc. | 07 Mar 2025 | 1 | $0 | 4 | Director | 11 Mar 2025, 16:20 |
| SNTI | Senti Biosciences, Inc. | 10 Jul 2024 | 1 | $0 | 4 | Director | 12 Jul 2024, 16:15 |
| LXEO | Lexeo Therapeutics, Inc. | 25 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 17:05 |
| LXEO | Lexeo Therapeutics, Inc. | 02 Nov 2023 | 0 | $0 | 3 | Director | 02 Nov 2023, 21:19 |
| SNTI | Senti Biosciences, Inc. | 16 Jun 2023 | 1 | $0 | 4 | Director | 21 Jun 2023, 19:12 |
| SNTI | Senti Biosciences, Inc. | 13 Jul 2022 | 1 | $0 | 4 | Director | 15 Jul 2022, 18:00 |
| SNTI | Senti Biosciences, Inc.\ | 08 Jun 2022 | 0 | $0 | 3 | Director | 15 Jun 2022, 18:01 |